SCHEMBL26641065

SCHEMBL26641065

O=C1CCC(c2ccc(CC3(F)CCNCC3)cc2)C(=O)N1

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 19/20 0.54
▸ DDB1 Q16531 18/20 0.54
▸ POLB P06746 1/20 0.47
▸ GSPT1 P15170 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26641449 0.87 CRBN (0.51) CRBNDDB1POLBGSPT1
SCHEMBL30643700 0.85 CRBN (0.54) CRBNDDB1POLB
SCHEMBL31585504 0.78 CRBN (0.56) CRBNDDB1POLBGSPT1
SCHEMBL26641290 0.77 CRBN (0.66) CRBNDDB1POLBGSPT1
SCHEMBL25217869 0.76 CRBN (0.64) CRBNDDB1POLBGSPT1
SCHEMBL26641368 0.76 CRBN (0.54) CRBNDDB1POLBGSPT1
SCHEMBL26641328 0.76 CRBN (0.54) CRBNDDB1POLBGSPT1
SCHEMBL24125814 0.76 CRBN (0.64) CRBNDDB1POLB
SCHEMBL25187957 0.76 CRBN (0.64) CRBNDDB1POLB
SCHEMBL25935699 0.76 CRBN (0.65) CRBNDDB1POLBGSPT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522613-A1 CDK PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS Biotheryx, Inc. (US) 2025-03-19 — — EP claimed
WO-2023220640-A1 CDK PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-11-16 — — WO claimed
CN-120092003-A CDK protein degrading agents, pharmaceutical compositions and therapeutic uses 拜欧斯瑞克斯公司 2025-06-03 — — CN disclosed
WO-2023220640-A1 CDK PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-11-16 — — WO disclosed
Send feedback